The stock of Allergan seems to be on a one-way path of struggle and endless competition, CNBC’s Jim Cramer said on Thursday. “It can’t catch a break,” the “Mad Money” host told a caller in the lightning round. “Sage Therapeutics has got a competitive drug to something that they may be doing for depression. The […]
Read moreOn Thursday, Reuters reported that China’s ride-hailing giant Didi Chuxing will launch in Mexico next year. The move would mark Didi’s first expansion of its services beyond China. It also underscores Didi’s existential threat to Uber, its U.S. counterpart. The companies now share a major investor in Softbank, which has led to speculation they would […]
Read moreU.S. markets finished higher on Thursday ahead of Asia’s Friday trading day as investors awaited developments regarding tax reform. In Asia, markets will await the release of trade data out of China for clues about the health of its economy. Tax reform was in focus on Wall Street as investors anticipated potentially lower corporate taxes […]
Read moreWith the CBOE, CME and Nasdaq hopping aboard the bitcoin train to offer their own derivatives of the wildly popular cryptocurrency, CNBC’s Jim Cramer issued a warning about the craze. “After its recent ascent, bitcoin’s become some sort of abstruse casino game that seems to have only winners and no losers. You’ve got to like […]
Read moreBitcoin futures are set to begin trading Sunday at the CBOE and a week later at the CME, and retail brokerages are bracing. Interactive Brokers‘ founder Tom Peterffy said on CNBC’s “Fast Money” on Thursday, his concern is that the cryptocurrency could continue to rise to $100,000 or more before crashing to zero, and could […]
Read moreIt’s easy to call the market “crazy” or “irrational” in the face of an unexpected sell-off like the one that happened in the technology stocks this week, CNBC’s Jim Cramer said on Thursday. “But the market’s not crazy, nor is it irrational,” the “Mad Money” host said. “In reality, traders tend to make wild over-generalizations. […]
Read moreThe U.S. Food and Drug Administration just released its guidance on a category of software called “clinical decision support,” which is designed to help doctors make more data-driven decisions about patient care. It sounds wonky, but companies for years have been begging for clarity on whether this type of software is regulated — or it […]
Read moreEmployers are expected to have added about 200,000 jobs in November and wage growth was seen as strong, two trends reinforcing that the Federal Reserve will raise rates when it meets next week. The employment report, expected at 8:30 a.m. ET, is expected to show the unemployment rate held at 4.1 percent, and average hourly […]
Read moreAdvocates on both sides of the net neutrality debate are calling out Google for apparent hypocrisy this week after it blocked YouTube from working on Amazon’s FireTV product. People who watch a lot of YouTube videos through their Amazon streaming devices got a nasty surprise Tuesday when YouTube announced it would cut its video service […]
Read moreDespite Facebook’s $2 billion bet on Oculus and virtual reality products from Samsung, Sony and Google, VR hasn’t gone mainstream. But the founder of HTC’s Vive headset business is more bullish than ever. Phil Chen left HTC in 2015 and is now a partner at Li Ka-Shing’s Horizons Ventures and the co-founder of a VR-focused […]
Read more